Abstract
Deliberate drug overdose is a frequent occurrence in patients with schizophrenia. Typical antipsychotic medications can be lethal at doses 5 times the recommended therapeutic range. Clozapine, an atypical antipsychotic, can be toxic at doses 4 times a moderate dose. Little is known about the lethal effects of the novel antipsychotic risperidone, despite the fact that it is now one of the most widely prescribed antipsychotics in North America. To date, only 1 death attributable to risperidone overdose has been reported. The case presented here documents adverse cardiac effects in a 28-year-old man who intentionally ingested 24 mg of risperidone--4 times the recommended dose. A potential drug interaction with fluvoxamine and the role of active metabolites are discussed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burgess K. R., Jefferis R. W., Stevenson I. F. Fatal thioridazine cardiotoxicity. Med J Aust. 1979 Aug 25;2(4):177–178. doi: 10.5694/j.1326-5377.1979.tb142025.x. [DOI] [PubMed] [Google Scholar]
- Cheslik T. A., Erramouspe J. Extrapyramidal symptoms following accidental ingestion of risperidone in a child. Ann Pharmacother. 1996 Apr;30(4):360–363. doi: 10.1177/106002809603000407. [DOI] [PubMed] [Google Scholar]
- Darby J. K., Pasta D. J., Elfand L., Dabiri L., Clark L., Herbert J. Risperidone dose and blood level variability: accumulation effects and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting. J Clin Psychopharmacol. 1997 Dec;17(6):478–484. doi: 10.1097/00004714-199712000-00007. [DOI] [PubMed] [Google Scholar]
- Himstreet J. E., Daya M. Hypotension and orthostasis following a risperidone overdose. Ann Pharmacother. 1998 Feb;32(2):267–267. doi: 10.1345/aph.17168. [DOI] [PubMed] [Google Scholar]
- Joubert P. H., Olivier J. A. Fatal suicidal ingestion of thioridazine. Clin Toxicol. 1974 Apr;7(2):133–138. doi: 10.3109/15563657408987988. [DOI] [PubMed] [Google Scholar]
- Leysen J. E., Gommeren W., Eens A., de Chaffoy de Courcelles D., Stoof J. C., Janssen P. A. Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther. 1988 Nov;247(2):661–670. [PubMed] [Google Scholar]
- Lo Vecchio F., Hamilton R. J., Hoffman R. J. Risperidone overdose. Am J Emerg Med. 1996 Jan;14(1):95–96. doi: 10.1016/s0735-6757(96)90026-1. [DOI] [PubMed] [Google Scholar]
- McDougle C. J., Fleischmann R. L., Epperson C. N., Wasylink S., Leckman J. F., Price L. H. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. J Clin Psychiatry. 1995 Nov;56(11):526–528. [PubMed] [Google Scholar]
- Meeker J. E., Herrmann P. W., Som C. W., Reynolds P. C. Clozapine tissue concentrations following an apparent suicidal overdose of Clozaril. J Anal Toxicol. 1992 Jan-Feb;16(1):54–56. doi: 10.1093/jat/16.1.54. [DOI] [PubMed] [Google Scholar]
- Spina E., Pollicino A. M., Avenoso A., Campo G. M., Perucca E., Caputi A. P. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects. Ther Drug Monit. 1993 Jun;15(3):243–246. doi: 10.1097/00007691-199306000-00011. [DOI] [PubMed] [Google Scholar]
- Springfield A. C., Bodiford E. An overdose of risperidone. J Anal Toxicol. 1996 May-Jun;20(3):202–203. doi: 10.1093/jat/20.3.202. [DOI] [PubMed] [Google Scholar]
- Sproule B. A., Naranjo C. A., Brenmer K. E., Hassan P. C. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence. Clin Pharmacokinet. 1997 Dec;33(6):454–471. doi: 10.2165/00003088-199733060-00004. [DOI] [PubMed] [Google Scholar]